Adial Pharmaceuticals, Inc.
ADIL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001513525
In the last 90 days, Adial Pharmaceuticals, Inc. insiders filed 3 open-market purchases and 0 sales; 17 institutions reported holding it in 13F filings for Q2 2026, worth $334.6K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Adial Pharmaceuticals, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 3 filings
- 1 insider, $106.3K in total
- Open-market sells
- 0 filings
- Insiders trading
- 1
- Net value
- +$106.3K
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Adial Pharmaceuticals, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Young Wendy B. | Director | – | Sep 21, 2026 | 2 |
| Coastlands Capital LP | 10% Owner | 388,308Indirect | Jul 16, 2026 | 3 |
| Davidson Matt | Chief Development Officer | 1,923Indirect | Jun 16, 2026 | 1 |
| Claiborne Cary J | Chief Executive Officer | 40,417 | Apr 9, 2026 | 1 |
| Goodman Tony | Chief Operating Officer | 26,523 | Apr 9, 2026 | 1 |
| Anderson J. Kermit | Director | – | Apr 9, 2026 | 1 |
| Schuyler Kevin | Director | 9,213 | Apr 9, 2026 | 1 |
| Gilliland Robertson H. | Director | 9,185 | Apr 9, 2026 | 1 |
| Shah Vinay | Chief Financial Officer | 17,325 | Apr 9, 2026 | 1 |
| Newman James W. Jr. | Director | 34,644Indirect | Jun 2, 2025 | 0 |
| Truluck Joseph | Chief Financial Officer | 265,139 | Mar 27, 2024 | 0 |
| Johnson Bankole A. | Director | 148,246Indirect | Jun 2, 2023 | 0 |
| Stilley William B. III | Director | 1,261,779 | May 25, 2023 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jul 16, 2026 (view filing)5:08 PM ET | Jul 14-16 | 2 days | Coastlands Capital LP10% Owner | PPurchase | +3.23K | $2.69 | +$8.69K | +0.8%388.3K after | 2 lots |
| Jul 13, 2026 (view filing)10:30 AM ET | Jul 9-10 | 4 days | Coastlands Capital LP10% Owner | PPurchase | +11.8K | $2.78 | +$32.6K | +3.1%385.1K after | 2 lots |
| Jul 1, 2026 (view filing)10:30 AM ET | Jun 29 | 2 days | Coastlands Capital LP10% Owner | PPurchase | +25.0K | $2.60 | +$65.0K | +7.2%373.3K after | |
| Jun 16, 2026 (view filing) | Jun 12 | 4 days | Young Wendy B.Director | PPurchase | +36.4K | $2.75 | +$100.0K | –36.4K after | Derivative |
| Oct 3, 2023 (view filing) | Sep 29 | 4 days | Schuyler KevinDirector | PPurchase | +700 | $2.74 | +$1.92K | New position700 after | |
| Jan 3, 2022 (view filing) | Dec 30, 2021 | 4 days | Newman James W. Jr.Director | PPurchase | +10.0K | $2.66 | +$26.6K | +100.0%20.0K after | |
| Jan 3, 2022 (view filing) | Dec 30, 2021 | 4 days | Newman James W. Jr.Director | PPurchase | +15.0K | $2.71 | +$40.7K | +76.4%34.6K after | 2 lots |
| Dec 1, 2021 (view filing) | Nov 29-30 | 2 days | Stilley William B. IIIChief Executive Officer | PPurchase | +20.6K | $2.67 | +$55.0K | +2.2%937.6K after | 2 lots |
| Nov 30, 2021 (view filing) | Nov 26 | 4 days | Newman James W. Jr.Director | PPurchase | +10.0K | $2.85 | +$28.5K | +40.9%34.5K after | |
| Oct 6, 2021 (view filing) | Oct 4 | 2 days | Johnson Bankole A.Chief Medical Officer | SSale | −200.0K | – | – | −57.4%148.2K after |